The molecule target is to the treatment achievement "

The molecule target is to the treatment achievement " It is cured that different with the disease " Model
Author: Pan Feng

It is reported the intersection of molecule and target to treat it is nearly 10 over year that come the intersection of bed and receiving much concern hot subject under oncological research, and make progress in the treatments of diseases such as lung cancer, breast cancer,etc.. European Union medicines administration bureau (EMEA) Accredited taking small molecule epidermis factor kinase inhibitor hydroxyphenylaminopropionic acid orally a few days ago - -Not lucky for the Buddhist nun, can be used for treating the epidermis growth factor receptor (EGFR) The person who didn't get cellule lung cancer of gene mutation, including a gleam of treatment after diagnosing. As to this, academician of Chinese Academy of Engineering, internal medicine - oncology Sun Yan in the tumour hospital of Chinese Academy of Medical Sciences say, it sanctions to be can in sensitive crowd as first-selected a gleam of treatment in Europe for Nicaragua while being lucky, signify the intersection of molecule and target to treat in some common the intersection of tumour and being treated the intersection of status and further rise, and make the foundation of this important decision, it is mainly the research results from Asian clinical oncologist.

It is reported, what is initiated and launched by the scientist of our country is study at two critical III stages - -INTEREST and IPASS have made very important achievement in succession. INTEREST study, reveal, compared with chemotherapy of standard Line two, have surviving always equal for Buddhist nun while being lucky time and fine the intersection of life and quality benefit; And it prove, to the Asian descendant patient who is chosen, compared with uniting chemotherapy two times that IPASS studies, use the intersection of airline and having life cycling such as progress, relieving rate, tolerance, the intersection of life and the intersection of quality and respect of benefiting objectively therapeutic for for Buddhist nun while being lucky, there is advantage of statistics significance. The scholar of our country will be in U.S.A.'s clinical oncological annual meeting (ASCO) in Europe, 2009 for the first time in 2008 Have reported these two research.

Yan Sun say of our country scholar in the intersection of cellule and the intersection of lung cancer and the intersection of molecule and to treat achievements made in the clinical research target, it is our country " It is cured that different with the disease " Model. Target, to treat, must find appropriate some target, curative effect could give play to, choose different patients of terms clinically, the curative effect to the treatment medicine of the molecule target is different too. The decision which European Union medicines administration bureau makes, has reflected and made a diagnosis the individual importance, this will undoubtedly lead clinical tumour to enter a new era.

The molecule target is to the treatment achievement " It is cured that different with the disease " Model